Nasal Obstruction
3
Pipeline Programs
2
Companies
6
Clinical Trials
2
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
2
Early DiscoveryClinical DevelopmentMarket
On Market (2)
Approved therapies currently available
U
MOMETASONE FUROATEApproved
mometasone furoate
Unknown Companynasal2025
U
SINUVAApproved
mometasone furoate
Unknown Companyimplantation2017
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Aerin MedicalCA - Mountain View
5 programsVivaer Arc StylusN/A1 trial
Vivaer StylusN/A1 trial
Vivaer StylusN/A1 trial
Vivaer StylusN/A1 trial
Vivaer StylusN/A1 trial
Active Trials
+2 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
T-TherapeuticsMometasone furoate
Aerin MedicalVivaer Arc Stylus
Aerin MedicalVivaer Stylus
Aerin MedicalVivaer Stylus
Aerin MedicalVivaer Stylus
Aerin MedicalVivaer Stylus
Clinical Trials (6)
Demonstrate the Therapeutic Clinical Equivalence of Two Mometasone Nasal Sprays
Start: Oct 2012Est. completion: Mar 2013
Phase 3Unknown
The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)
Start: Sep 2021Est. completion: Oct 2024
N/ACompleted
Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction
Start: Feb 2020Est. completion: Oct 2024
N/ACompleted
Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Start: Oct 2017Est. completion: Jul 2022
N/ACompleted
Treatment Outcome Using Vivaer Stylus to Treat Nasal Airway Obstruction
Start: Sep 2017Est. completion: Aug 2019
N/ACompleted
Treatment of Nasal Airway Obstruction Using the Aerin Medical Device
Start: Sep 2016Est. completion: Aug 2017
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space